Correlation Between Madrigal Pharmaceuticals and Immatics Biotechnologies
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Immatics Biotechnologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Immatics Biotechnologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and immatics biotechnologies GmbH, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Immatics Biotechnologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Immatics Biotechnologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Immatics Biotechnologies.
Diversification Opportunities for Madrigal Pharmaceuticals and Immatics Biotechnologies
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Madrigal and Immatics is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and immatics biotechnologies GmbH in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immatics Biotechnologies and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Immatics Biotechnologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immatics Biotechnologies has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Immatics Biotechnologies go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Immatics Biotechnologies
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.91 times more return on investment than Immatics Biotechnologies. However, Madrigal Pharmaceuticals is 1.1 times less risky than Immatics Biotechnologies. It trades about 0.31 of its potential returns per unit of risk. immatics biotechnologies GmbH is currently generating about -0.63 per unit of risk. If you would invest 21,700 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 11,974 from holding Madrigal Pharmaceuticals or generate 55.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 86.36% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. immatics biotechnologies GmbH
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Immatics Biotechnologies |
Madrigal Pharmaceuticals and Immatics Biotechnologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Immatics Biotechnologies
The main advantage of trading using opposite Madrigal Pharmaceuticals and Immatics Biotechnologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Immatics Biotechnologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics Biotechnologies will offset losses from the drop in Immatics Biotechnologies' long position.| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals | Madrigal Pharmaceuticals vs. Seres Therapeutics |
| Immatics Biotechnologies vs. Eliem Therapeutics | Immatics Biotechnologies vs. Scpharmaceuticals | Immatics Biotechnologies vs. Milestone Pharmaceuticals | Immatics Biotechnologies vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |